Please login to the form below

Not currently logged in
Email:
Password:

Evotec CEO Werner Lanthaler temporarily stands down

Cites health reasons

Evotec's CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.

Dr Lanthaler informed the supervisory board of his situation, and the board approved approved his leave of absence. It also wished Dr Lanthaler an early recovery.

The management board of Dr Cord Dohrmann and Colin Bond, under the direction of Dr Mario Polywka, the chief operating officer, will lead the company in the absence of Dr Lanthaler.

He will reassume the role of CEO as soon as he has recovered.

5th October 2012

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Gem Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...